PE: What alternate strategies would have a better impact on reducing drug costs? Mendelsohn: Pushing for lower out-of-pocket ...

Selarsdi, a biosimilar to Stelara, is approved for adult and pediatric psoriatic arthritis, plaque psoriasis, Crohn disease, ...

Chip Parkinson, CEO, GiftHealth, explains how AI-powered data integration is bringing new hope to patients by revealing ...

Medicare drug price negotiations will reshape market access, provider reimbursement, and patient care ...

The 470,000-square-foot facility will support the launch and commercial production of next-generation biologics and therapies ...

Tiara Green, president, Accessia Health, explains how empowering trusted local leaders and involving communities early are ...